Glucagon like peptide-1 receptor agonists as neuroprotective agents for ischemic stroke: a systematic scoping review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucagon like peptide-1 receptor agonists as neuroprotective agents for ischemic stroke: a systematic scoping review
Authors
Keywords
-
Journal
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Volume -, Issue -, Pages 0271678X2095201
Publisher
SAGE Publications
Online
2020-09-21
DOI
10.1177/0271678x20952011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lixisenatide Reduced Damage in Hippocampus CA1 Neurons in a Rat Model of Cerebral Ischemia-Reperfusion Possibly Via the ERK/P38 Signaling Pathway
- (2020) Salma N. Gad et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Treatment With Liraglutide Exerts Neuroprotection After Hypoxic–Ischemic Brain Injury in Neonatal Rats via the PI3K/AKT/GSK3β Pathway
- (2020) Shan-shan Zeng et al. Frontiers in Cellular Neuroscience
- Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus
- (2020) Valeria Raparelli et al. Journal of the American Heart Association
- The Neurovascular Unit: Effects of Brain Insults During the Perinatal Period
- (2020) Alexander H. Bell et al. Frontiers in Neuroscience
- The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial
- (2020) Hertzel C Gerstein et al. Lancet Diabetes & Endocrinology
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
- (2019) Yue Fei et al. Cardiovascular Diabetology
- Role of liraglutide in brain repair promotion through Sirt1‐mediated mitochondrial improvement in stroke
- (2019) Weiliang He et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Prehospital exenatide in hyperglycemic stroke—A randomized trial
- (2019) Martin Larsson et al. ACTA NEUROLOGICA SCANDINAVICA
- The diabetes drug semaglutide reduces infarct size, inflammation, and apoptosis, and normalizes neurogenesis in a rat model of stroke
- (2019) Xiaoyan Yang et al. NEUROPHARMACOLOGY
- Effect of adding GLP-1RA on mortality, cardiovascular events, and metabolic outcomes among insulin-treated patients with type 2 diabetes: A large retrospective UK cohort study
- (2018) Uchenna Anyanwagu et al. AMERICAN HEART JOURNAL
- Neuroprotective effect of glucagon-like peptide-1 receptor agonist is independent of glycaemia normalization in type two diabetic rats
- (2018) Irina Filchenko et al. Diabetes & Vascular Disease Research
- Lixisenatide ameliorates cerebral ischemia-reperfusion injury via GLP-1 receptor dependent/independent pathways
- (2018) Rania G. Abdel-latif et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Treatment with exenatide in acute ischemic stroke trial protocol: A prospective, randomized, open label, blinded end-point study of exenatide vs. standard care in post stroke hyperglycemia
- (2018) Claire Muller et al. International Journal of Stroke
- Delayed Administration of the Glucagon-Like Peptide 1 Analog Liraglutide Promoting Angiogenesis after Focal Cerebral Ischemia in Mice
- (2018) Yanxia Chen et al. Journal of Stroke & Cerebrovascular Diseases
- Lixisenatide, a novel GLP-1 analog, protects against cerebral ischemia/reperfusion injury in diabetic rats
- (2018) Rania G. Abdel-latif et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Delayed Administration of the Glucagon-Like Peptide 1 Analog Liraglutide Promoting Angiogenesis after Focal Cerebral Ischemia in Mice
- (2018) Yanxia Chen et al. Journal of Stroke & Cerebrovascular Diseases
- Liraglutide Activates the Nrf2/HO-1 Antioxidant Pathway and Protects Brain Nerve Cells against Cerebral Ischemia in Diabetic Rats
- (2018) Caihong Deng et al. Computational Intelligence and Neuroscience
- Neuroprotection of rhGLP-1 in diabetic rats with cerebral ischemia/reperfusion injury via regulation of oxidative stress, EAAT2, and apoptosis
- (2018) Yi Fang et al. DRUG DEVELOPMENT RESEARCH
- GSK-3 inhibition through GLP-1R allosteric activation mediates the neurogenesis promoting effect of P7C3 after cerebral ischemic/reperfusional injury in mice
- (2018) Yea-Hwey Wang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Clinical Impact of 5 Years of Liraglutide Treatment on Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus in a Real-Life Setting in Italy: An Observational Study
- (2018) Vera Frison et al. Diabetes Therapy
- Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- (2018) Johannes F. E. Mann et al. CIRCULATION
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden
- (2018) Henrik Svanström et al. Lancet Diabetes & Endocrinology
- Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke
- (2017) Yazhou Li et al. EXPERIMENTAL NEUROLOGY
- Delayed administration of the GLP-1 receptor agonist liraglutide improves metabolic and functional recovery after cerebral ischemia in rats
- (2017) Wenbin Dong et al. NEUROSCIENCE LETTERS
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-inflammatory Effect of Glucagon Like Peptide-1 Receptor Agonist, Exendin-4, through Modulation of IB1/JIP1 Expression and JNK Signaling in Stroke
- (2017) Soojin Kim et al. Experimental Neurobiology
- The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice
- (2016) Ping-Chia Li et al. BMC NEUROSCIENCE
- Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study
- (2016) E. Patorno et al. DIABETES OBESITY & METABOLISM
- Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register
- (2016) Nils Ekström et al. DIABETES OBESITY & METABOLISM
- Neuroprotective Effects of rhGLP-1 in Diabetic Rats with Cerebral Ischemia/Reperfusion Injury
- (2016) Daoli Jiang et al. DRUG DEVELOPMENT RESEARCH
- Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes
- (2016) Uchenna Anyanwagu et al. HEART
- The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia
- (2016) Fangzhe Chen et al. Journal of Neuroinflammation
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
- (2016) Mayank Goyal et al. LANCET
- A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat
- (2016) Ling Han et al. NEUROREPORT
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exendin-4 Inhibits Matrix Metalloproteinase-9 Activation and Reduces Infarct Growth After Focal Cerebral Ischemia in Hyperglycemic Mice
- (2016) Takuma Kuroki et al. STROKE
- Activation of GLP-1 Receptor Enhances Neuronal Base Excision Repair via PI3K-AKT-Induced Expression of Apurinic/Apyrimidinic Endonuclease 1
- (2016) Jenq-Lin Yang et al. Theranostics
- Rationale and design of Short-Term EXenatide therapy in Acute ischaemic Stroke (STEXAS): a randomised, open-label, parallel-group study
- (2016) Rachel T McGrath et al. BMJ Open
- An Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke
- (2016) Huinan Zhang et al. PLoS One
- Intranasal Delivery of Exendin-4 Confers Neuroprotective Effect Against Cerebral Ischemia in Mice
- (2015) Huinan Zhang et al. AAPS Journal
- Protective effect of rhGLP-1 (7–36) on brain ischemia/reperfusion damage in diabetic rats
- (2015) Libo Zhao et al. BRAIN RESEARCH
- The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study
- (2015) Sanjoy K Paul et al. Cardiovascular Diabetology
- Pro-GLP-1, a Pro-drug of GLP-1, is neuroprotective in cerebral ischemia
- (2015) Huinan Zhang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Risk of cardiovascular disease: The effects of diabetes and anti-diabetic drugs — A nested case–control study
- (2015) Michael Gejl et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Exendin-4-Loaded PLGA Microspheres Relieve Cerebral Ischemia/Reperfusion Injury and Neurologic Deficits through Long-Lasting Bioactivity-Mediated Phosphorylated Akt/eNOS Signaling in Rats
- (2015) Chiang-Ting Chien et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- TNFα in cerebral ischemia: another stroke against you?
- (2015) Heather M. Wilkins et al. JOURNAL OF NEUROCHEMISTRY
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway
- (2015) Yu Jia et al. PHARMACOLOGICAL RESEARCH
- Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia
- (2014) S. Briyal et al. NEUROSCIENCE
- Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization
- (2014) Vladimer Darsalia et al. PLoS One
- Neuroprotective Effects of Liraglutide for Stroke Model of Rats
- (2013) Kenichiro Sato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exenatide in Acute Ischemic Stroke
- (2013) Samantha C. Daly et al. International Journal of Stroke
- Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
- (2013) Christian Hölscher JOURNAL OF ENDOCRINOLOGY
- Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
- (2013) Valery L Feigin et al. LANCET
- Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
- (2012) Christian Hölscher CNS DRUGS
- Neuroprotection for Ischaemic Stroke: Translation from the Bench to the Bedside
- (2012) Brad A. Sutherland et al. International Journal of Stroke
- Effects of vascular endothelial growth factor in ischemic stroke
- (2012) Yihui Ma et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats
- (2011) Seema Briyal et al. BRAIN RESEARCH
- PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration
- (2011) Ganta Chaitanya et al. Cell Communication and Signaling
- Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats
- (2011) Vladimer Darsalia et al. CLINICAL SCIENCE
- Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Provides Neuroprotection in Mice Transient Focal Cerebral Ischemia
- (2011) Shinichiro Teramoto et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia
- (2011) Choong Hyun Lee et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A retrospective analysis of the LifeLink database
- (2010) J. H. Best et al. DIABETES CARE
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
- (2010) Carol Kilkenny et al. PLOS BIOLOGY
- GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
- (2009) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
- (2009) Marc Fisher et al. STROKE
- The clinical implications of ageing for rational drug therapy
- (2008) Shaojun Shi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Analysis of apoptosis by cytometry using TUNEL assay
- (2008) Zbigniew Darzynkiewicz et al. METHODS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started